| Athletes (n = 205) | Controls (n = 458) | OR (95% CI) | P-value |
---|---|---|---|---|
Haplotype (3 sites) -511, +3954, IL-1RN)a | Haplotype Frequency | Haplotype Frequency | Â | 0.012 |
C-C-L | 0.360 | 0.406 | 1.0 (reference) | 0.029 |
C-C-S | 0.117 | 0.093 | 1.420 (0.862-2.339) | 0.095 |
C-T-L | 0.106 | 0.160 | 0.745 (0.436-1.274) | 0.051 |
C-T-S | 0.049 | 0.018 | 3.016 (1.156-7.867) | 0.011 |
T-C-L | 0.171 | 0.178 | 1.082 (0.711-1.648) | 0.838 |
T-C-S | 0.133 | 0.107 | 1.400 (0.891-2.200) | 0.054 |
T-T-L | 0.042 | 0.027 | 1.762 (0.692-4.487) | 0.484 |
T-T-S | 0.022 | 0.011 | 2.226 (0.492-10.080) | 0.043 |
Haplotype (2 sites) | Â | Â | Â | Â |
-511, +3954 | Â | Â | Â | 0.264 |
C-C | 0.478 | 0.498 | 1.0 (reference) | 0.278 |
C-T | 0.154 | 0.179 | 0.896 (0.608-1.321) | 0.520 |
T-C | 0.303 | 0.286 | 1.105 (0.815-1.498) | 0.258 |
T-T | 0.065 | 0.038 | 1.809 (0.889-3.679) | 0.103 |
+3954, IL-1RN | Â | Â | Â | 0.001 |
C-L | 0.529 | 0.584 | 1.0 (reference) | 0.023 |
C-S | 0.251 | 0.200 | 1.386 (1.013-1.897) | 0.012 |
T-L | 0.149 | 0.187 | 0.879 (0.597-1.292 | 0.183 |
T-S | 0.071 | 0.029 | 2.658 (1.345-5.254) | 0.003 |
-511, IL-1RN | Â | Â | Â | 0.003 |
C-L | 0.465 | 0.566 | 1.0 (reference) | 0.001 |
C-S | 0.166 | 0.111 | 1.821 (1.213-2.732) | 0.014 |
T-L | 0.214 | 0.205 | 1.267 (0.894-1.795) | 0.954 |
T-S | 0.155 | 0.118 | 1.589 (1.099-2.298) | 0.025 |